Product
Botulinum Toxin A
6 clinical trials
7 indications
Indication
Peyronie's DiseaseIndication
Hemifacial SpasmIndication
Plantar FasciitisIndication
Cerebral PalsyIndication
strokeIndication
Chronic PainIndication
Lower Extremity WoundClinical trial
The Efficacy of Botulinum Toxin Type a in Treating Peyronie's DiseaseStatus: Completed, Estimated PCD: 2017-02-15
Clinical trial
A 50-Week Prospective, Double-Blinded, Randomized, Cross-over Design in Multicenter Study of100 Unit of Abobotulinum Toxin Type A (Dysport®) Versus 33.33 Unit of Neubotulinum Toxin Type A (Neuronox®) Injection for Hemifacial Spasm in Thai PatientsStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
The Efficacy of Botulinum Toxin to the Flexor Digitorum Brevis Versus Corticosteroid to the Plantar Fascia for the Treatment of Refractory Plantar Fasciitis: A Randomized-Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-04-26
Clinical trial
Combined Effect of Repetitive Transcranial Magnetic Stimulation and Botulinum Injection on Spasticity and Motor Functions of Children With Diplegic Cerebral PalsyStatus: , Estimated PCD: 2024-01-20
Clinical trial
SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTSStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities, a Prospective Exploratory StudyStatus: Recruiting, Estimated PCD: 2023-11-01